Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
3(18%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
7
41%
Ph not_applicable
2
12%
Ph phase_1
4
24%
Ph phase_2
3
18%

Phase Distribution

11

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution16 total trials
Early Phase 1First-in-human
7(43.8%)
Phase 1Safety & dosage
4(25.0%)
Phase 2Efficacy & side effects
3(18.8%)
N/ANon-phased studies
2(12.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

17

all time

Status Distribution
Active(5)
Completed(11)
Other(1)

Detailed Status

Completed11
Recruiting3
Not yet recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 17 (43.8%)
Phase 14 (25.0%)
Phase 23 (18.8%)
N/A2 (12.5%)

Trials by Status

not_yet_recruiting212%
recruiting318%
completed1165%
unknown16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07503002Phase 1

Shortened LSD Intervention for Major Depressive Disorder

Not Yet Recruiting
NCT07017478Early Phase 1

Mood Effects of Serotonin Agonists: Depression

Completed
NCT07061886Early Phase 1

Drug Effects on Mood and Behavior - Expectancy

Completed
NCT07490405

Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism

Not Yet Recruiting
NCT05474989Phase 2

LSD Treatment for Persons With Alcohol Use Disorder

Recruiting
NCT07309471Not Applicable

Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD

Recruiting
NCT03866252Phase 2

LSD Therapy for Persons Suffering From Major Depression

Completed
NCT06899334Phase 1

Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants

Recruiting
NCT04227756Phase 1

Comparative Acute Effects of LSD, Psilocybin and Mescaline

Completed
NCT05670184Phase 1

The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality

Unknown
NCT03153579Phase 2

LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders

Completed
NCT03604744Early Phase 1

Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin

Completed
NCT03321136Early Phase 1

Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study)

Completed
NCT03019822Early Phase 1

Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing

Completed
NCT02451072Not Applicable

The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers

Completed
NCT01878942Early Phase 1

Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled Study

Completed
NCT02308969Early Phase 1

Neuronal Correlates of Altered States of Consciousness

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17